The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Cancer genetics and genomics of human FOX family genes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Datta, J., Kutay, H., Nasser, M. W., Nuovo, G. J., Wang, B., Majumder, S., Liu, C.-G., Volinia, S., Croce, C. M., Schmittgen, T. D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6655 · Cited by 438
RetractedBao, B., Wang, Z., Ali, S., Kong, D., Banerjee, S., Ahmad, A., Li, Y., Azmi, A. S., Miele, L., & Sarkar, F. H. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23150 · Cited by 206
RetractedAhmad, A., Wang, Z. P., Kong, D., Ali, S. S., Li, Y., Banerjee, S., Raza, A., & Sarkar, F. H. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0572-1 · Cited by 138
RetractedA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan-Smith, E., Dalton, J. D., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,801
Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5
Clark, K. L., Halay, E. D., Lai, E., & Burley, S. K. (1993) · Nature · doi:10.1038/364412a0 · Cited by 1,274
Opening of Compacted Chromatin by Early Developmental Transcription Factors HNF3 (FoxA) and GATA-4
Cirillo, L. A., Lin, F. R., Cuesta, I., Friedman, D., Jarnik, M., & Zaret, K. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00459-8 · Cited by 1,185
The emerging roles of forkhead box (Fox) proteins in cancer
Myatt, S. S., & Lam, E. W. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2223 · Cited by 1,070
Hybrid error correction and de novo assembly of single-molecule sequencing reads
Koren, S., Schatz, M. C., Walenz, B. P., Martin, J., Howard, J. T., Ganapathy, G., Wang, Z., Rasko, D. A., McCombie, W. R., Jarvis, E. D., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2280 · Cited by 1,011
FOXO3A genotype is strongly associated with human longevity
Willcox, B. J., Donlon, T. A., He, Q., Chen, R., Grove, J. S., Yano, K., Masaki, K. H., Willcox, D. C., Rodriguez, B., & Curb, J. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801030105 · Cited by 983
The MDM2 gene amplification database
Momand, J. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.15.3453 · Cited by 982
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer
Frescas, D., & Pagano, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2396 · Cited by 890
Forkhead Transcription Factors: Key Players in Development and Metabolism
Carlsson, P., & Mahlapuu, M. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0780 · Cited by 840
Manning, A. K., Hivert, M.-F., Scott, R. A., Grimsby, J. L., Bouatia-Naji, N., Chen, H., Rybin, D., Liu, C.-T., Bielak, L. F., Prokopenko, I., et al. (2012) · Nature Genetics · doi:10.1038/ng.2274 · Cited by 827
Weigel, D., Jürgens, G., Küttner, F., Seifert, E., & Jäckle, H. (1989) · Cell · doi:10.1016/0092-8674(89)90133-5 · Cited by 782
Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
Shah, S. P., Köbel, M., Senz, J., Morin, R. D., Clarke, B. A., Wiegand, K. C., Leung, G., Zayed, A., Mehl, E., Kalloger, S. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902542 · Cited by 768
The evolution of Fox genes and their role in development and disease
Hannenhalli, S., & Kaestner, K. H. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2523 · Cited by 658
Wang, I.-C., Chen, Y.-J., Hughes, D., Petrovic, V., Major, M. L., Park, H. J., Tan, Y., Ackerson, T., & Costa, R. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.10875-10894.2005 · Cited by 627
Mani, S. A., Yang, J., Brooks, M., Schwaninger, G., Zhou, A., Miura, N., Kutok, J. L., Hartwell, K., Richardson, A. L., & Weinberg, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703900104 · Cited by 575
Almeida, M., Han, L., Martin-Millan, M., O'Brien, C. A., & Manolagas, S. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702811200 · Cited by 548
FOXP2 as a molecular window into speech and language
Fisher, S. E., & Scharff, C. (2009) · Trends in Genetics · doi:10.1016/j.tig.2009.03.002 · Cited by 542
Stankiewicz, P., Sen, P., Bhatt, S. S., Storer, M., Xia, Z., Bejjani, B. A., Ou, Z., Wiszniewska, J., Driscoll, D. J., Bolivar, J., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.05.005 · Cited by 535
Katoh, Y., & Katoh, M. (2009) · Current Molecular Medicine · doi:10.2174/156652409789105570 · Cited by 525
Self-citationThe Foxa family of transcription factors in development and metabolism
Friedman, J. R., & Kaestner, K. H. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6095-6 · Cited by 515
Human FOX gene family (Review)
Katoh, M., & Katoh, M. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.5.1495 · Cited by 504
Self-citationPierrou, S., Hellqvist, M., Samuelsson, L., Enerbäck, S., & Carlsson, P. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06827.x · Cited by 441
Zuo, T., Wang, L., Morrison, C., Chang, X., Zhang, H., Li, W., Liu, Y., Wang, Y., Liu, X., Chan, M. W. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.034 · Cited by 395
Sahu, B., Laakso, M., Ovaska, K., Mirtti, T., Lundin, J., Rannikko, A., Sankila, A., Turunen, J., Lundin, M., Konsti, J., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.328 · Cited by 390
Foxa1 and Foxa2 Are Essential for Sexual Dimorphism in Liver Cancer
Li, Z., Tuteja, G., Schug, J., & Kaestner, K. H. (2012) · Cell · doi:10.1016/j.cell.2011.11.026 · Cited by 382
Laganière, J., Deblois, G., Lefebvre, C., Bataille, A. R., Robert, F., & Giguère, V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505575102 · Cited by 367
FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
Teh, M., Wong, S.-T., Neill, G. W., Ghali, L. R., Philpott, M. P., & Quinn, A. (2002) · PubMed · Cited by 356
Fox's in development and disease
Lehmann, O. J., Sowden, J. C., Carlsson, P., Jordan, T., & Bhattacharya, S. S. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00111-2 · Cited by 350
Foxp1 is an essential transcriptional regulator of B cell development
Hu, H., Wang, B., Borde, M., Nardone, J., Maika, S., Allred, L., Tucker, P. W., & Rao, A. (2006) · Nature Immunology · doi:10.1038/ni1358 · Cited by 328
Lai, E., Clark, K. L., Burley, S. K., & Darnell, J. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10421 · Cited by 327
Forkhead transcription factors: key players in health and disease
Benayoun, B. A., Caburet, S., & Veitia, R. A. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.03.003 · Cited by 301
Mizuno, T., Murakami, H., Fujii, M., Ishiguro, F., Tanaka, I., Kondo, Y., Akatsuka, S., Toyokuni, S., Yokoi, K., Osada, H., et al. (2012) · Oncogene · doi:10.1038/onc.2012.5 · Cited by 279
Gao, N., Zhang, J., Rao, M. A., Case, T. C., Mirosevich, J., Wang, Y., Jin, R., Gupta, A., Rennie, P. S., & Matusik, R. J. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0020 · Cited by 279
Unravelling the tumor-suppressive functions of FOXO proteins
Dansen, T. B., & Burgering, B. M. T. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.07.004 · Cited by 268
Banham, A. H., Beasley, N. J. P., Campo, E., Fernández, P. L., Fidler, C., Gatter, K. C., Jones, M. M., Mason, D. Y., Prime, J. E., Trougouboff, P., et al. (2001) · PubMed · Cited by 251
Identification of a Chemical Inhibitor of the Oncogenic Transcription Factor Forkhead Box M1
Radhakrishnan, S. K., Bhat, U. G., Hughes, D. E., Wang, I.-C., Costa, R. H., & Gartel, A. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1576 · Cited by 234
Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c
Ma, R. Y. M., Tong, T. H. K., Cheung, A. M. S., Tsang, A. C. C., Leung, W. Y., & Yao, K.-M. (2005) · Journal of Cell Science · doi:10.1242/jcs.01657 · Cited by 231
A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer
Yang, J.-Y., & Hung, M.-C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0124 · Cited by 228
Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers
Sérandour, A. A., Avner, S., Percevault, F., Demay, F., Bizot, M., Lucchetti-Miganeh, C., Barloy-Hubler, F., Brown, M., Lupien, M., Métivier, R., et al. (2011) · Genome Research · doi:10.1101/gr.111534.110 · Cited by 226
Sekiya, T., Muthurajan, U. M., Luger, K., Tulin, A. V., & Zaret, K. S. (2009) · Genes & Development · doi:10.1101/gad.1775509 · Cited by 221
Barrans, S. L., Fenton, J. A. L., Banham, A., Owen, R. G., & Jack, A. S. (2004) · Blood · doi:10.1182/blood-2004-03-1209 · Cited by 218
Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate
Wang, L., Liu, R., Li, W., Chen, C., Katoh, H., Chen, G.-Y., McNally, B., Lin, L., Zhou, P., Zuo, T., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.016 · Cited by 218
Genetic Advances in the Study of Speech and Language Disorders
Newbury, D. F., & Monaco, A. P. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.001 · Cited by 218
Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes
Hu, X., Stern, H. M., Ge, L., O'Brien, C., Haydu, L., Honchell, C. D., Haverty, P. M., Peters, B. A., Wu, T. D., Amler, L. C., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0107 · Cited by 217
MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation
Fu, W., Ma, Q., Chen, L., Li, P., Zhang, M., Ramamoorthy, S., Nawaz, Z., Shimojima, T., Wang, H., Yang, Y., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901758200 · Cited by 201
Gemenetzidis, E., Bose, A., Riaz, A. M., Chaplin, T., Young, B. D., Ali, M., Sugden, D., Thurlow, J. K., Cheong, S.-C., Teo, S.-H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004849 · Cited by 188
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression
Klampfl, T., Harutyunyan, A., Berg, T., Gisslinger, B., Schalling, M., Bagienski, K., Olcaydu, D., Passamonti, F., Rumi, E., Pietra, D., et al. (2011) · Blood · doi:10.1182/blood-2011-01-331678 · Cited by 185
Robbins, C. M., Tembe, W. A., Baker, A., Sinari, S., Moses, T. Y., Beckstrom-Sternberg, S., Beckstrom-Sternberg, J., Barrett, M., Long, J., Chinnaiyan, A., et al. (2011) · Genome Research · doi:10.1101/gr.107961.110 · Cited by 180
Zhang, H., Meng, F., Liu, G., Zhang, B., Zhu, J., Wu, F., Ethier, S. P., Miller, F., & Wu, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2825 · Cited by 177
Genetic parameters of neuroblastomas
Westermann, F., & Schwab, M. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00199-4 · Cited by 173
FOXP1: a potential therapeutic target in cancer
Koon, H. B., Ippolito, G. C., Banham, A. H., & Tucker, P. W. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.7.955 · Cited by 170
FOXQ1 Regulates Epithelial-Mesenchymal Transition in Human Cancers
Qiao, Y., Jiang, X., Lee, S. T., Karuturi, R. K. M., Hooi, S. C., & Yu, Q. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2787 · Cited by 168
Craig, V. J., Cogliatti, S. B., Imig, J., Renner, C., Neuenschwander, S., Rehrauer, H., Schlapbach, R., Dirnhofer, S., Tzankov, A., & Müller, A. (2011) · Blood · doi:10.1182/blood-2010-10-312231 · Cited by 166
Landa, I., Ruiz-Llorente, S., Montero-Conde, C., Inglada-Pérez, L., Schiavi, F., Leskelä, S., Pita, G., Milne, R., Maravall, J., Ramos, I., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000637 · Cited by 164
Pioneer factors: directing transcriptional regulators within the chromatin environment
Magnani, L., Eeckhoute, J., & Lupien, M. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.07.002 · Cited by 160
Zaret, K. S., Watts, J., Xu, J., Wandzioch, E., Smale, S. T., & Sekiya, T. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.040 · Cited by 160
Liu, X., Zhang, Z., Sun, L. J., Chai, N., Tang, S., Jin, J., Hu, H., Nie, Y., Wang, X., Wu, K., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr213 · Cited by 150
Forkhead box M1 transcription factor: A novel target for cancer therapy
Wang, Z. P., Ahmad, A., Li, Y., Banerjee, S., Kong, D., & Sarkar, F. H. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.11.006 · Cited by 148
Dong, X.-Y., Chen, C., Sun, X., Guo, P., Vessella, R. L., Wang, R.-X., Chung, L. W. K., Zhou, W., & Dong, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0411 · Cited by 140
Chan, D. W., Yu, S., Chiu, P., Yao, K., Liu, V., Cheung, A., & Ngan, H. (2008) · The Journal of Pathology · doi:10.1002/path.2355 · Cited by 134
Forkhead Box, Class O Transcription Factors in Brain: Regulation and Behavioral Manifestation
Polter, A. M., Yang, S., Zmijewska, A. A., van Groen, T., Paik, J.-H., DePinho, R. A., Peng, S. L., Jope, R. S., & Li, X. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.005 · Cited by 128
Lin, L., Miller, C. T., Contreras, J. I., Prescott, M. S., Dagenais, S. L., WU, R. T., Yee, J., Orringer, M. B., Misek, D. E., Hanash, S., et al. (2002) · PubMed · Cited by 128
Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis
Thorat, M. A., Marchiò, C., Morimiya, A., Savage, K., Nakshatri, H., Reis-Filho, J. S., & Badve, S. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.052431 · Cited by 124
Genome profiling of pancreatic adenocarcinoma
Birnbaum, D. J., Adélaïde, J., Mamessier, E., Finetti, P., Lagarde, A., Monges, G., Viret, F., Gonçalvès, A., Turrini, O., Delpero, J., et al. (2011) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20870 · Cited by 122
Yu, J., Deshmukh, H., Payton, J. E., Dunham, C. P., Scheithauer, B. W., Tihan, T., Prayson, R. A., Guha, A., Bridge, J. A., Ferner, R. E., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1551 · Cited by 118
Zhang, Y., Li, S., Yuan, L., Tian, Y., Weidenfeld, J., Yang, J., Liu, F., Chokas, A. L., & Morrisey, E. E. (2010) · Genes & Development · doi:10.1101/gad.1929210 · Cited by 113
Xue, Y., Cao, R., Nilsson, D., Chen, S., Westergren, R., Hedlund, E.-M., Martijn, C., Rondahl, L., Krauli, P., Walum, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802486105 · Cited by 112
The pathogenesis of MALT lymphomas: where do we stand?
Sagaert, X., Wolf-Peeters, C. D., Noels, H., & Baens, M. (2007) · Leukemia · doi:10.1038/sj.leu.2404517 · Cited by 108
Common variants in FOXP1 are associated with generalized vitiligo
Jin, Y., Birlea, S. A., Fain, P. R., Mailloux, C. M., Riccardi, S. L., Gowan, K., Holland, P. J., Bennett, D. C., Wallace, M. R., McCormack, W. T., et al. (2010) · Nature Genetics · doi:10.1038/ng.602 · Cited by 105
Truncated ETV1, Fused to Novel Tissue-Specific Genes, and Full-Length ETV1 in Prostate Cancer
Hermans, K. G., van der Korput, H. A., van Marion, R., van de Wijngaart, D. J., der Made, A. Z., Dits, N. F. J., Boormans, J. L., van der Kwast, T., van Dekken, H., Bangma, C. H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5930 · Cited by 102
Zhang, C., Wang, L., Wu, D., Chen, H., Chen, Z., Thomas‐Ahner, J. M., Zynger, D. L., Eeckhoute, J., Yu, J., Luo, J., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1882 · Cited by 101
Fox, S. B., Brown, P., Han, C., Ashe, S., Leek, R., Harris, A. L., & Banham, A. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0461 · Cited by 98
Structure and functions of powerful transactivators: VP16, MyoD and FoxA
Hirai, H., Tani, T., & Kikyo, N. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103194hh · Cited by 93
Watson, J. E. V., Doggett, N. A., Albertson, D. G., Andaya, A., Chinnaiyan, A. M., van Dekken, H., Ginzinger, D. G., Haqq, C. M., James, K., Kamkar, S., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207474 · Cited by 90
Epigenetic Inactivation of the Potential Tumor Suppressor Gene FOXF1 in Breast Cancer
Lo, P., Lee, J. S., Liang, X., Han, L., Mori, T., Fackler, M. J., Sadik, H., Argani, P., Pandita, T. K., & Sukumar, S. V. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1576 · Cited by 87
Gene expression of forkhead transcription factors in the normal and diseased human prostate
van der Heul-Nieuwenhuijsen, L., Dits, N. F. J., & Jenster, G. W. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08351.x · Cited by 84
Toma, M. I., Großer, M., Herr, A., Aust, D. E., Meye, A., Hoefling, C., Fuessel, S., Wuttig, D., Wirth, M. P., & Baretton, G. B. (2008) · Neoplasia · doi:10.1593/neo.08160 · Cited by 83
FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma
Nucera, C., Eeckhoute, J., Finn, S. P., Carroll, J. S., Ligon, A. H., Priolo, C., Fadda, G., Toner, M. E., Sheils, O. M., Attard, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3155 · Cited by 83
Cuesta, I., Zaret, K. S., & Santisteban, P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00758-07 · Cited by 80
RBP2‐H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells
Roesch, A., Mueller, A. M., Stempfl, T., Moehle, C., Landthaler, M., & VOGT, T. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.23211 · Cited by 79
Priller, M., Pöschl, J., Abrão, L., von Bueren, A. O., Cho, Y., Rutkowski, S., Kretzschmar, H. A., & Schüller, U. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1214 · Cited by 77
Xia, J., Wang, H., Liang, L., Peng, B., Wu, Z., Chen, L., Xue, L., Li, Z., & Li, W. (2012) · Pancreas · doi:10.1097/mpa.0b013e31823bcef2 · Cited by 77
Transcriptional up‐regulation of FoxM1 in response to hypoxia is mediated by HIF‐1
Xia, L., Huang, W., Wang, B., Liu, M., Zhang, Q., Yan, W., Zhu, Q., Luo, M., Zhou, Z., & Tian, D. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21996 · Cited by 76
Mh, Y., Lin, B.-R., Chang, C., Chen, S.-T., Lin, S.-K., Kuo, M. Y.-P., Jeng, Y., Kuo, M.-L., & Chang, C. (2011) · Oncogene · doi:10.1038/onc.2011.423 · Cited by 73
FOXC2 is a Novel Prognostic Factor in Human Esophageal Squamous Cell Carcinoma
Nishida, N., Mimori, K., Yokobori, T., Sudo, T., Tanaka, F., Shibata, K., Ishii, H., Doki, Y., & Mori, M. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1274-y · Cited by 70
Brancaccio, A., Minichiello, A., Grachtchouk, M. A., Antonini, D., Sheng, H., Parlato, R., Dathan, N. A., Dlugosz, A. A., & Missero, C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh292 · Cited by 69
FOXP2 as a molecular window into speech and language
Fisher, S. E. (2013) · Cited by 69
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma
Santo, E. E., Ebus, M. E., Köster, J., Schulte, J. H., Lakeman, A., Sluis, P. V., Vermeulen, J., Gisselsson, D., Øra, I., Lindner, S., et al. (2011) · Oncogene · doi:10.1038/onc.2011.344 · Cited by 68
Nilsson, J., Helou, K., Kovács, A., Bendahl, P., Bjursell, G., Fernö, M., Carlsson, P., & Kannius‐Janson, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1677 · Cited by 68
The Forkhead factor FoxQ1 influences epithelial differentiation
Feuerborn, A., Srivastava, P. K., Küffer, S., Grandy, W. A., Sijmonsma, T., Gretz, N., Brors, B., & Gröne, H. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22385 · Cited by 67
Chen, Y., Zheng, B., Robbins, D. H., Lewin, D., Mikhitarian, K., Graham, A. S., Rumpp, L., Glenn, T. F., Gillanders, W. E., Cole, D. J., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22487 · Cited by 66
Reagan‐Shaw, S., & AHMAD, N. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.003 · Cited by 60
Ubiquitination, phosphorylation, and acetylation—triple threat in muscle wasting
Hasselgren, P. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21190 · Cited by 57
van Dongen, M. J. P., Cederberg, A., Carlsson, P., Enerbäck, S., & Wikström, M. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3476 · Cited by 55
Green, M. R., Aya‐Bonilla, C., Gandhi, M. K., Lea, R. A., Wellwood, J., Wood, P., Marlton, P. V., & Griffiths, L. R. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20856 · Cited by 53
Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma
Zhang, Y., Zhang, S., Wang, X., Liu, J., Yang, L., He, S., Chen, L., & Huang, J. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200547 · Cited by 52
Hedgehog pathway activation in human transitional cell carcinoma of the bladder
Pignot, G., Vieillefond, A., Vacher, S., Zerbib, M., Debré, B., Lidereau, R., Amsellem‐Ouazana, D., & Bièche, I. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.55 · Cited by 52
FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma
Venza, I., Visalli, M., Tripodo, B., Grazia, G. D., Loddo, S., Teti, D. V., & Venza, M. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09560.x · Cited by 52
Wang, M., & Gartel, A. L. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0536 · Cited by 52
FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing’s sarcoma cells
Yang, L., Hu, H., Zielinska‐Kwiatkowska, A., & Chansky, H. A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.129 · Cited by 47
Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia
Ernst, T., Score, J., Deininger, M. W., Hidalgo-Curtis, C., Lackie, P. M., Ershler, W. B., Goldman, J. M., Cross, N. C. P., & Grand, F. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08457.x · Cited by 46
Müssig, K., Staiger, H., Machicao, F. E., Stančáková, A., Kuusisto, J., Laakso, M., Thamer, C., Machann, J., Schick, F., Claussen, C. D., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1048 · Cited by 42
Brenkman, A. B., van den Broek, N. J. F., de Keizer, P. L. J., van Gent, D. C., & Burgering, B. M. T. (2010) · The FASEB Journal · doi:10.1096/fj.10-158717 · Cited by 41
Lo, P., Lee, J. S., & Sukumar, S. V. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.09.017 · Cited by 35
Huynh, K. M., Soh, J., Dash, R., Sarkar, D., Fisher, P. B., & Kang, D. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22326 · Cited by 31
Oteiza, A., & Mechti, N. (2011) · Journal of Virology · doi:10.1128/jvi.00036-11 · Cited by 30
The forkhead transcription factor FOXO4 sensitizes cancer cells to doxorubicin-mediated cytotoxicity
Lüpertz, R., Chovolou, Y., Unfried, K., Kampkötter, A., Wätjen, W., & Kahl, R. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn184 · Cited by 30
Li, C., Chae, S., Lee, J.-H., Zhang, Q., & Chung, H. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0359-8 · Cited by 26
Lin, M. C., Guo, L., Liu, H., Du, J., Yang, H. J., Zhang, L. J., & Zhang, B. (2010) · PubMed · doi:10.14670/hh-25.1269 · Cited by 22
Identification and characterization of human FOXN5 and rat Foxn5 genes in silico
Katoh, M., & Katoh, M. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.5.1339 · Cited by 22
Self-citationFOXK2 transcription factor is a novel G/T-mismatch DNA binding protein
Fujii, Y., & Nakamura, M. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq004 · Cited by 20
Böttcher, Y., Tönjes, A., Enigk, B., Scholz, G. H., Blüher, M., Stümvoll, M., & Kovacs, P. L. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.02.005 · Cited by 18
Oxidative Stress-Dependent Regulation of Forkhead Box O4 Activity by Nemo-Like Kinase
Szypowska, A. A., de Ruiter, H., Meijer, L. A. T., Smits, L. M. M., & Burgering, B. M. T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3243 · Cited by 14
Cited by
FGF Receptors: Cancer Biology and Therapeutics: CANCER BIOLOGY AND THERAPEUTICS ON FGF RECEPTORS
Katoh, M., & Nakagama, H. (2014) · Medicinal Research Reviews · doi:10.1002/med.21288 · Cited by 610
Self-citationGenome-Informed Targeted Therapy for Osteosarcoma
Sayles, L. C., Breese, M. R., Koehne, A. L., Leung, S. G., Lee, A. G., Liu, H.-Y., Spillinger, A., Shah, A. T., Tanasa, B., Straessler, K., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1152 · Cited by 452
“FOXM1 is involved in cell-cycle control and is amplified and overexpressed in several tumor types including basal-type breast cancer and diffuse large B-cell lymphoma (40).”
BackgroundAkagi, K., Li, J., Broutian, T. R., Padilla-Nash, H., Xiao, W., Jiang, B., Rocco, J. W., Teknos, T. N., Kumar, B., Wangsa, D., et al. (2014) · Genome Research · doi:10.1101/gr.164806.113 · Cited by 468
Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis
Dong, B., Lee, J.-S., Park, Y.-Y., Yang, F., Xu, G., Huang, W., Finegold, M. J., & Moore, D. D. (2015) · Nature Communications · doi:10.1038/ncomms6944 · Cited by 97
Guryanova, O. A., Lieu, Y. K., Garrett-Bakelman, F. E., Spitzer, B., Glass, J. L., Shank, K., Martinez, A. B. V., Rivera, S. A., Durham, B. H., Rapaport, F., et al. (2016) · Leukemia · doi:10.1038/leu.2015.358 · Cited by 66
Metadata
- Authors
- Katoh, M., Igarashi, M., Fukuda, H., Nakagama, H., & Katoh, M.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 328
- Issue
- 2
- Pages
- 198-206
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2055167407
- Cited by
- 401
- References
- 122
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.